Abetimus sodium - Treatment of systemic lupus etythematosus

Authors
Sorbera, LA Castaner, RM Revel, L
Citation
La. Sorbera et al., Abetimus sodium - Treatment of systemic lupus etythematosus, DRUG FUTURE, 26(7), 2001, pp. 633-638
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUGS OF THE FUTURE
ISSN journal
03778282 → ACNP
Volume
26
Issue
7
Year of publication
2001
Pages
633 - 638
Database
ISI
SICI code
0377-8282(200107)26:7<633:AS-TOS>2.0.ZU;2-W
Abstract
DNA d(C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A), 5'-ester with 1,2-ethanedly lbis(oxy-2,1-ethanediyl)bis[2-(21,21-dihydroxy-21-oxido-4,11-dioxo-20-oxa-1 3-thia-3,10-diaza-21-phosphaheneicos-1-yl)-23,23-dihydroxy-23-oxido-6,13-di oxo-22-oxa-15-thia-2,5,12-triaza-23-phosphatricosanoate] (4:1), complex wit h DNA d(T-G-T-G-T-G-T-G-T-G-T-G-T-G-TG-T-G-T-G) (1:1), hexapentacontahectas odium salt. Deoxyribonucleic acid d(C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A-C-A), 5'-ester with 1,2-ethanediylbis(oxy-2,1-ethanediyl)bis[2-(21,21-dihydroxy-4,11-dioxo -20-oxa-13-thia-3,10-diaza-21-phosphaeneicos-1-yl)-23,23-dihydroxy-6,13- di oxo-22-oxa-15-thia-2,5,12-triaza-23-phosphatricosanoate] (4:1), P,P',23,23' -tetraoxide, complex with deoxyribonucleic acid d(T-G-T-G-T-G-T-G-T-G-T-G-T -G-T-G-T-G-T-G) (1:1), hexapentacontahectasodium salt.